Home
Our company
We pioneer breakthroughs in healthcare.
For everyone. Everywhere. Sustainably.
Our purpose
When our health is at risk, we rely on physicians to make the best possible decisions – from quick, early diagnoses to the most effective treatments and follow-ups. By constantly bringing breakthrough innovations to market, we help healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients.
Our portfolio of products, services, and solutions is at the center of clinical decision-making and treatment pathways. Patient-centered innovation has been and always will be at the core of our company. We aspire to create better outcomes and experiences for patients no matter where they live or what they are facing.
We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
This is why we give our best every day, to improve the lives of patients and their families.
Our products, services, and solutions
With our comprehensive portfolio – from in-vitro diagnostics and best-in-class imaging to therapy and follow-up care – we address the complete care continuum for many of the world’s most threatening diseases.
Did you know?
of all critical clinical decisions are influenced by the type of technology we provide. We are at the center of clinical decision making.
technical intellectual property rights, thereof more than 15,000 granted patents; constantly bringing breakthrough innovations to market – for the benefit of patients, medical professionals, and society. (As of October 2023)
Our innovation leadership
Our unique combination of strengths set us apart and enable us to actively shape the transformation of healthcare:
- Patient twinning: We expand precision medicine with utmost personalization of diagnosis, therapy selection, aftercare, and managing health. This helps us understand the patient as completely as possible.
- Precision therapy: We address the most prevalent diseases with intelligent and image-guided treatment.
- Digital, Data & AI: We drive digitalization by leveraging digital, data, and artificial intelligence (AI) and advancing providers’ operations with technology-enabled services
We will continue to build on these strengths to help overcome the world’s most threatening diseases: cancer, cardiovascular and neurovascular diseases, improving the quality of outcomes, and enabling access to care.
Tackling a global challenge
Global business, local care
Even the most advanced technology is only as good as the number of people who have access to it. That's why innovation must be followed by scalability. This means solutions that can be tailored to the needs of our customers, the healthcare providers, and the local infrastructures, in which they are integrated.
What all healthcare systems have in common is their demand for high-value care – providing better outcomes with fewer resources. And while medtech is a global business, healthcare is inherently local.
We are currently present in more than 70 countries around the globe, making sure we are close to our customers. Our products, solutions, and services are customized to meet local market needs, benefiting from an unmatched global expertise.
Our innovation legacy
Built on a history of innovation we are a global player with a strong engineering heritage. Just one year after X-rays were discovered by Wilhelm Conrad Roentgen in 1895, we created our company’s first medical X-ray device.
Our archives still hold a letter from Roentgen dating back to 1896 praising the quality of tubes provided by Siemens.
Want to take a peek into our archives?
Visit the pages of our Siemens Healthineers MedMuseum to discover more stories from our past.
Pioneering breakthroughs are in our DNA
1933: Pantix X-ray tube
This design, with a diskshaped rotating anode, is still the basis of X-ray tubes to this day.
1958: Gamma camera
By capturing an entire organ at once, this scintillation camera gave rise to modern SPECT technology.
1967: Vidoson
The world's first ultrasound system to allow real-time observation of movements inside the body.
1990: Somatom Plus-S
Spiral CT paved the way for the future of computed tomography technology.
Varian’s high-resolution, digital beam shaping device ushered in the era of intensity-modulated radiation therapy (IMRT).
Varian’s integrated solution featuring the most powerful particle accelerator available today to treat cancer.
2016: Atellica® Solution
A revolutionary clinical chemistry and immunodiagnostics system.
2017: Magnetom Terra
The first ultra-high-field (7T) scanner released for clinical use in Europe and the U.S.
Varian’s AI-driven holistic solution enables the delivery of an adaptive radiotherapy treatment for cancer within a typical 15-minute timeslot.
Our smallest, most lightweight and virtually helium-free whole-body MRI with the world's first 80 cm bore sets a new paradigm in magnetic resonance imaging.
World’s first clinical CT system with photon-counting detection technology.
1933: Pantix X-ray tube
This design, with a diskshaped rotating anode, is still the basis of X-ray tubes to this day.
Our legacy lives on
Today, our engineers and researchers worldwide continue to build upon our legacy of innovation. Backed by an annual research and development investment of €1.5 billion and about 24,000 technical intellectual property rights, including more than 15,000 granted patents, we constantly bring breakthrough innovations to market – for the benefit of patients, medical professionals, and society.
Our culture
We are a team of more than 73,000 highly dedicated employees pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.
A culture of inclusivity
Our responsibility
An inclusive culture is a pre-requisite if we aspire to serve the eight billion people on our planet. As a diverse organization, we can better relate to the people – whether customers or patients – their communities and the specific challenges they face. Diversity, equity, and inclusion are therefore important aspects of our wider responsibilities.
Contributing to the United Nations Sustainable Development Goals is a priority of our business strategy and is continuously enabled by our unique culture. We are a member of the UN Global Compact, our emissions reduction targets are approved by the Science Based Targets initiative (SBTi) as consistent with levels required to meet the goals of the Paris Agreement.
Our sustainability strategy is built on three pillars. We commit to improving healthcare access for all, limiting our environmental impact as we pioneer breakthroughs, and engaging our diverse Healthineers to achieve this impact on a global scale. We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
What is the Science Based Targets initiative (SBTi)?
Our management
As the company's top management body, the members of the Managing Board, Bernd Montag (CEO), Jochen Schmitz (CFO), Darleen Caron (CHRO), and Elisabeth Staudinger (MBM) are committed to serving the interests of Siemens Healthineers and achieving sustainable growth in company value.
A publicly listed company
To secure the financial strength and entrepreneurial flexibility needed to continue pioneering breakthroughs in healthcare, Siemens spun off its medtech business in 2016 and Siemens Healthineers was born. In 2018, we successfully went public on the Frankfurt Stock Exchange and in 2021 we were promoted to the DAX, Germany’s most important stock market index.
What's in a name?
Our purpose is to drive innovation to help humans live healthier and longer, and our mission is to enable healthcare providers worldwide increase value. These goals are expressed in our company name.
We chose a name that makes us stand out – one that, above all else, reflects the people who work here; people who pioneer and engineer in healthcare.
Our strategy
With our joint purpose, values, and our unique combination of strengths, we are taking the next step in the evolution of our company, serving even more customers and patients, and setting ourselves even more ambitious targets. In recent years, we have been growing into adjacent markets with the acquisitions of ECG Management Consultants, Corindus, and the transformative combination of Siemens Healthineers and Varian. During our New Ambition phase, we will focus on these strategic priorities:
- Our ambition is to leverage our strong core in imaging and robotics to expand our relevance in cardiovascular and neurovascular care. And building on our oncology leadership by expanding along the diagnostic and therapeutic disease pathway.
- Our ambition is to enable healthcare providers to better serve more patients by augmenting and automating manual workflows.
Our ambition is to become a trusted partner to healthcare systems and patients by addressing the most pressing needs and enable healthcare for everyone, everywhere.
Combining the strength of our people, knowledge, and portfolio, we passionately pursue our single and unifying purpose: We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
